European markets edged higher on Monday’s session, but lingering fears the China might get back on the U.S. capped gains.
The pan-European Stoxx 600 was found trading higher by around 0.1 percent early in the session, with most sectors and major markets holding on to positive positions.
Europe’s health-care stocks led the gains on Monday morning, which was up 0.5 percent amid news of a lung cancer trial success.
Looking at individual stocks, Fresnillo surged towards the top of the European benchmark after a rating upgrade from Goldman Sachs.
The U.S. investment bank raised its stock recommendation to “buy” and added the stock to its conviction list. Shares of Fresnillo were trading 3.5 percent higher on the news.
In the U.S. President Donald Trump signed a memorandum on Friday that could see charges implemented on up to $60 billion of imports from Beijing, though the measures have a 30-day consultation period before they take effect.
The tariffs follow additional duties on steel and aluminum imports on a number of countries worldwide, including China, with the world’s second largest economy hitting back with its own plans to impose charges on up to $3 billion of U.S. Imports.
Turning back to Europe, The International Monetary Fund (IMF) Managing Director Christine Lagarde is ready to deliver a speech on the future of the Single currency at around 9 a.m. in London.